Staff Reporters
Sep 17, 2008

McCann wins Oxycontin brief

SINGAPORE - Mundipharma has appointed McCann Healthcare Worldwide to develop a regional branding platform for Oxycontin, an opiate-based painkiller for cancer.

McCann wins Oxycontin brief
According to John Cahill, the agency has been briefed to re-launch Oxycontin in Asia-Pacific as well as differentiate the brand from the key competitor. “The campaign will aim to have doctors perceive and prescribe Oxycontin as the first-choice opioid,” he said.

In addition, Inovail Holdings has tasked McCann Healthcare Worldwide with developing its regional strategy and campaign development for the brand Kinerase - a clinic and pharmacy-sold skincare range. The brand is available over-the-counter in the US and other parts of the world, with Courtney Cox as its US brand ambassador.

Related Articles

Just Published

4 hours ago

StackAdapt launches integrated platform to connect ...

Marketers can now use one workflow to trigger emails from ad views and personalise campaigns using real-time purchase signals.

5 hours ago

Heineken trusts Korean football fans with keys to ...

An activation in Seoul sees Korean fans ordering, paying for, and pulling their own pints without bar owners or security present. Just to be able to watch live football.

5 hours ago

Why sports marketing should lean into intimate, ...

In a world shaped by Gen Z and hyper-local engagement, the winning brands aren’t the loudest—they’re the ones that create authentic experiences that foster belonging and build trust.

6 hours ago

Woolley Marketing: How much transparency is too ...

Trust in advertiser-agency relationships hinges not on absolute transparency, but on reasonable openness that empowers both sides without drowning them in irrelevant details, says Darren Woolley.